Dengue: a continuing global threat.
Dengue fever and dengue haemorrhagic fever are important arthropod-borne viral diseases. Each year, there are ∼50 million dengue infections and ∼500,000 individuals are hospitalized with dengue haemorrhagic fever, mainly in Southeast Asia, the Pacific and the Americas. Illness is produced by any...
Enregistré dans:
| Auteur principal: | |
|---|---|
| Format: | Journal Article |
| Langue: | anglais |
| Publié: |
2018
|
| Accès en ligne: | https://demo7.dspace.org/handle/123456789/221 |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|
| _version_ | 1860822453089992704 |
|---|---|
| author | Simmons, Cameron |
| author_browse | Simmons, Cameron |
| author_facet | Simmons, Cameron |
| author_sort | Simmons, Cameron |
| collection | DSpace |
| description | Dengue fever and dengue haemorrhagic fever are important arthropod-borne viral diseases. Each year, there are ∼50 million dengue infections and ∼500,000 individuals are hospitalized with dengue haemorrhagic fever, mainly in Southeast Asia, the Pacific and the Americas. Illness is produced by any of the four dengue virus serotypes. A global strategy aimed at increasing the capacity for surveillance and outbreak response, changing behaviours and reducing the disease burden using integrated vector management in conjunction with early and accurate diagnosis has been advocated. Antiviral drugs and vaccines that are currently under development could also make an important contribution to dengue control in the future. |
| format | Journal Article |
| id | oai:localhost:123456789-221 |
| institution | DSPACE.FCHPT |
| language | eng |
| publishDate | 2018 |
| publishDateRange | 2018 |
| publishDateSort | 2018 |
| record_format | dspace |
| spelling | oai:localhost:123456789-2212021-04-07T16:30:08Z Dengue: a continuing global threat. Simmons, Cameron Dengue fever and dengue haemorrhagic fever are important arthropod-borne viral diseases. Each year, there are ∼50 million dengue infections and ∼500,000 individuals are hospitalized with dengue haemorrhagic fever, mainly in Southeast Asia, the Pacific and the Americas. Illness is produced by any of the four dengue virus serotypes. A global strategy aimed at increasing the capacity for surveillance and outbreak response, changing behaviours and reducing the disease burden using integrated vector management in conjunction with early and accurate diagnosis has been advocated. Antiviral drugs and vaccines that are currently under development could also make an important contribution to dengue control in the future. 2018-09-14T11:15:09Z 2018-08-09T10:14:16Z 2018-09-14T11:15:09Z 2010-12 Journal Article https://demo7.dspace.org/handle/123456789/221 eng |
| spellingShingle | Simmons, Cameron Dengue: a continuing global threat. |
| title | Dengue: a continuing global threat. |
| title_full | Dengue: a continuing global threat. |
| title_fullStr | Dengue: a continuing global threat. |
| title_full_unstemmed | Dengue: a continuing global threat. |
| title_short | Dengue: a continuing global threat. |
| title_sort | dengue a continuing global threat |
| url | https://demo7.dspace.org/handle/123456789/221 |
| work_keys_str_mv | AT simmonscameron dengueacontinuingglobalthreat |